Home >> Diseases & Conditions >> Government >> Food & Beverage >>

Botulism Global Clinical Trials Review, H2, 2014

Published: Nov-2014 | Format: PDF | GlobalData | Number of pages: 56 | Code: MRS - 1788

 

GlobalData's clinical trial report, “Botulism Global Clinical Trials Review, H2, 2014"" provides data on the Botulism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Botulism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Botulism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Botulism 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Botulism to Infectious Disease Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Botulism to Infectious Disease Clinical Trials 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Botulism 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Botulism Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Emergent BioSolutions Inc. 26
Clinical Trial Overview of Emergent BioSolutions Inc. 26
DynPort Vaccine Company LLC 27
Clinical Trial Overview of DynPort Vaccine Company LLC 27
Merz Pharma GmbH & Co. KgaA 28
Clinical Trial Overview of Merz Pharma GmbH & Co. KgaA 28
Medy-Tox Inc. 29
Clinical Trial Overview of Medy-Tox Inc. 29
Clinical Trial Overview of Top Institutes / Government 30
California Department of Public Health 30
Clinical Trial Overview of California Department of Public Health 30
Centre Hospitalier Universitaire, Amiens 31
Clinical Trial Overview of Centre Hospitalier Universitaire, Amiens 31
Chinese PLA General Hospital 32
Clinical Trial Overview of Chinese PLA General Hospital 32
FDA Office of Orphan Products Development 33
Clinical Trial Overview of FDA Office of Orphan Products Development 33
Rajavithi Hospital foundation 34
Clinical Trial Overview of Rajavithi Hospital foundation 34
The National Institute of Allergy and Infectious Diseases 35
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 35
Five Key Clinical Profiles 36

Appendix 54
Abbreviations 54
Definitions 54
Research Methodology 55
Secondary Research 55
About GlobalData 56
Contact Us 56
Disclaimer 56
Source 56

List of Tables

Botulism Therapeutics, Global, Clinical Trials by Region, 2014* 6
Botulism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Botulism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Botulism Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Botulism Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Botulism Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Botulism to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 12
Botulism Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Botulism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Botulism to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 15
Botulism Therapeutics, Global, Clinical Trials by Phase, 2014* 16
Botulism Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17
Botulism Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Botulism Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Botulism Therapeutics, Global, Suspended Clinical Trials, 2014* 20
Botulism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Botulism Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 22
Botulism Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Botulism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Botulism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
Botulism Therapeutics Clinical Trials Market, Global, Clinical Trials by Emergent BioSolutions Inc., 2014* 26
Botulism Therapeutics Clinical Trials Market, Global, Clinical Trials by DynPort Vaccine Company LLC, 2014* 27
Botulism Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharma GmbH & Co. KgaA, 2014* 28
Botulism Therapeutics Clinical Trials Market, Global, Clinical Trials by Medy-Tox Inc., 2014* 29
Botulism Therapeutics Clinical Trials Market, Global, Clinical Trials by California Department of Public Health, 2014* 30
Botulism Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire, Amiens, 2014* 31
Botulism Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese PLA General Hospital, 2014* 32
Botulism Therapeutics Clinical Trials Market, Global, Clinical Trials by FDA Office of Orphan Products Development, 2014* 33
Botulism Therapeutics Clinical Trials Market, Global, Clinical Trials by Rajavithi Hospital foundation, 2014* 34
Botulism Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 35"

List of Figures

Botulism Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Botulism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Botulism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Botulism Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Botulism Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 10
Proportion of Botulism to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 12
Botulism Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Botulism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Botulism to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 15
Botulism Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16
Botulism Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17
Botulism Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Botulism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Botulism Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 22
Botulism Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Botulism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 24
Botulism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
GlobalData Methodology 55

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing